In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. But Isomorphic’s initial focus is on small-molecule drug discovery, with protein-based drugs remaining a distant ...

A new startup founded by a former Google DeepMind scientist is exiting stealth with $50 million in funding. Latent Labs is building AI foundation models to “make biology programmable,” and it plans to ...

Isomorphic Labs, a spin-off of Google DeepMind and a subsidiary of Alphabet (NASDAQ:GOOGL) has planned to start clinical trials for AI-designed drugs by the end of this year, according to CEO ...

Alphabet’s artificial intelligence start-up Isomorphic Labs has made a splash at the start of the JP Morgan Healthcare conference this week, announcing its first pharma partnerships with Eli ...

Isomorphic Labs launches into an already well-populated drug discovery category, with many large drugmakers exploring the technology along with a host of specialist players like Exscientia ...

Famed chip maker and hardware giant Nvidia has been investing significant resources into the healthcare and life sciences ...

Radical Ventures partner, Aaron Rosenberg, the former Head of Strategy & Operations at DeepMind, where he contributed to spinning out Isomorphic Labs to build upon AlphaFold, said: “We’ve ...

“At the same time, I saw that with the launch of Isomorphic Labs, and their plans based on AlphaFold2, that they were starting many things at once. I felt like the opportunity was really in ...